Research News

Transcriptional repression by a secondary DNA binding surface of DNA topoisomerase I safeguards against hypertranscription

A team of scientists, led by N2CR member Dr. Tee Wee Wei, has identified the enzyme DNA topoisomerase I (TOP1) as a key regulator of gene activity crucial for normal development and health. Their discovery reveals that a specific disease-associated mutation (R548Q) in TOP1 accelerates gene activity, disrupting normal developmental programs. Tight control of gene activity is essential, as dysregulation can contribute to diseases, particularly in aggressive cancers characterized by transcriptional overdrive. Importantly, the mutation does not impact TOP1’s primary enzymatic function but hinders its ability to bind to DNA correctly. This research highlights TOP1 as a molecular rheostat, ensuring precise control of gene activity levels and maintaining appropriate total transcription levels in our cells.

Read more here: https://www.nature.com/articles/s41467-023-42078-9

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

ZBTB48: A New On-Switch for the Immune Response

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections and cancer …

Read More →
Research News

Magnetic Field Therapy Improves Breast Cancer Treatment with Fewer Side Effects

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, …

Read More →
Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →